研究目的
To evaluate the feasibility and ef?cacy of RCM-guided carbon dioxide (CO2) laser ablation of low-risk BCCs.
研究成果
RCM-guided laser ablation can detect subclinical BCC after initial ablation and potentially aid in increasing ef?cacy of laser treatments. RCM may emerge as a noninvasive tool to monitor different treatment modalities for BCC and other skin cancers.
研究不足
Relatively small sample size, short follow-up time, maximum image depth of RCM (200 to 250 μm), no histopathologic proof of clearance, performed in a tertiary cancer center with expertise in RCM.
1:Experimental Design and Method Selection:
Prospective study with biopsy specimen-proven low-risk BCCs imaged with RCM. RCM was performed before and after ablation. If residual tumor was found, additional laser passes were performed.
2:Sample Selection and Data Sources:
Adult patients with a history of multiple BCCs located on NCCN low-risk areas with biopsy specimen-proven BCCs.
3:List of Experimental Equipment and Materials:
Handheld RCM device (VivaScope 3000; Caliber ID), CO2 laser (Lumenis UltraPulse 5000C; Lumenis Inc), aluminum chloride (35%).
4:Experimental Procedures and Operational Workflow:
Preablation RCM, laser ablation under local anesthesia, immediate postablation RCM, and follow-up RCM at 3, 6, and 12 months.
5:Data Analysis Methods:
Evaluation of RCM images for residual tumor and clinical follow-up for recurrence.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容